StemBioSys, Inc. (StemBioSys) and CarTox, Inc. (Cartox) are pleased to announce that StemBioSys has acquired a majority stake in Cartox. StemBioSys will acquire all remaining equity of Cartox subject to the achievement of certain milestones.

Burzik has had a significant impact on the Alamo City and its successes in biotech. She was president and CEO of Kinetic Concepts Inc., a wound care company whose stock price doubled during her tenure, which included an expansion and diversification that moved the company into regenerative medicine with its $1.7 billion acquisition of LifeCell.

(San Antonio, September 9, 2019) – Pioneering San Antonio business leader and entrepreneur Catherine M. Burzik has been selected by the Advanced Medical Technology Association (AdvaMed) to receive its highest honor – the Lifetime Achievement Award – for her many contributions to the medical technology industry.

Warriewood, Australia, June 30, 2019 - AXT is pleased to announce it has further enhanced its cellular research product portfolio through the addition of stem cell solutions from StemBioSys. The recently signed agreement will see AXT distribute StemBioSys’ unique solutions to researchers in Australia and New Zealand.

SAN ANTONIO – StemBioSys Inc. announced today that it has entered into an agreement with AXT PTY LTD to distribute and market StemBioSys products. AXT will distribute StemBioSys products in Australia and New Zealand.